Acadia(AKR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AKR Acadia

Trading 08-28 12:17:06 EDT

20.89

-0.01

-0.05%

High21.06	Low20.85	Vol142.69K
Open21.04	D1 Closing20.90	Amplitude1.00%
Mkt Cap2.87B	Tradable Cap2.85B	Total Shares137.33M
T/O2.99M	T/O Rate0.10%	Tradable Shares136.63M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"AKR","market":"US","secType":"STK","nameCN":"Acadia","latestPrice":20.89,"timestamp":1787933814923,"preClose":20.9,"halted":0,"volume":142685,"delay":0,"changeRate":-0.0004784688995214359,"floatShares":136629693,"shares":137332700,"eps":0.337883,"marketStatus":"Trading","change":-0.01,"latestTime":"08-28 12:17:06 EDT","open":21.035,"high":21.06,"low":20.851,"amount":2988124.9653499997,"amplitude":0.01,"askPrice":20.9,"askSize":200,"bidPrice":20.88,"bidSize":8,"shortable":3,"etf":0,"ttmEps":0.337883,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787947200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":738475200000,"exchange":"NYSE","adjPreClose":20.9,"dividendRate":0.038305,"preHourTrading":{"tag":"盘前","latestPrice":21.09,"preClose":20.9,"latestTime":"09:29 EDT","volume":460,"amount":9663.588,"timestamp":1787923799999,"change":0.19,"changeRate":0.009091,"amplitude":0.016148},"postHourTrading":{"tag":"盘后","latestPrice":20.9,"preClose":20.9,"latestTime":"19:30 EDT","volume":33409,"amount":698248.1,"timestamp":1787873406863,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.310608,"impliedVol":0.2478,"impliedVolPercentile":0.5817},"requestUrl":"/m/hq/s/AKR/wiki","defaultTab":"wiki","newsList":[{"id":"2662199755","title":"Acadia Pharmaceuticals is Maintained at Buy by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2662199755","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662199755?lang=en_us&edition=fundamental","pubTime":"2026-08-25 23:37","pubTimestamp":1787672220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ACAD/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662736208","title":"Acadia Pharmaceuticals price target raised to $28 from $27 at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2662736208","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662736208?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:00","pubTimestamp":1787655611,"startTime":"0","endTime":"0","summary":"Morgan Stanley raised the firm’s price target on Acadia Pharmaceuticals (ACAD) to $28 from $27 and keeps an Equal Weight rating on the shares after...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/acadia-pharmaceuticals-price-target-raised-to-28-from-27-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/acadia-pharmaceuticals-price-target-raised-to-28-from-27-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662358127","title":"Acadia Pharmaceuticals price target raised to $40 from $39 at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2662358127","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662358127?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:05","pubTimestamp":1787652338,"startTime":"0","endTime":"0","summary":"Citi raised the firm’s price target on Acadia Pharmaceuticals (ACAD) to $40 from $39 and keeps a Buy rating on the shares ahead of the Phase 2 Alzh...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/acadia-pharmaceuticals-price-target-raised-to-40-from-39-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/acadia-pharmaceuticals-price-target-raised-to-40-from-39-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661749982","title":"Analysts’ Top Real Estate Picks: Macerich (MAC), Acadia Realty (AKR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661749982","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661749982?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:50","pubTimestamp":1787579421,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Real Estate sector as 2 analysts just weighed in on Macerich (MAC) and Acadia Realty (AKR) with bullish...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-real-estate-picks-macerich-mac-acadia-realty-akr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-real-estate-picks-macerich-mac-acadia-realty-akr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","BK4080","MAC","AKR","REIT","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661220803","title":"Acadia Pharmaceuticals Gets European Approval of Rett Syndrome Drug Daybu","url":"https://stock-news.laohu8.com/highlight/detail?id=2661220803","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661220803?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:06","pubTimestamp":1787565960,"startTime":"0","endTime":"0","summary":"Acadia Pharmaceuticals has won European Commission approval for its Daybu as a treatment for neurobehavioral symptoms of Rett syndrome in patients five and older.Acadia on Monday said the green light makes Daybu the first and only treatment approved in the European Union for Rett syndrome, a rare neurodevelopmental disorder.The San Diego drugmaker said it will now begin pricing and reimbursement negotiations with relevant national authorities across the EU.Acadia, which markets Daybu as Daybue in the U.S. and Canada, earlier this month said it expects global net product sales of the drug to reach $480 million to $510 million this year.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065169927.USD","BK4231","ACAD","LU2065171311.SGD","LU2065170008.USD","AKR","LU2065171402.SGD","EPV","BK4080","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660491965","title":"Acadia Realty Trust Shares Rise After KeyBanc Upgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2660491965","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660491965?lang=en_us&edition=fundamental","pubTime":"2026-08-19 02:42","pubTimestamp":1787078557,"startTime":"0","endTime":"0","summary":"Acadia Realty Trust  shares rose 1.2% in Tuesday trading after KeyBanc upgraded the stock to overweight from sector weight, with a price target of $25 per share.Trading volume stood at nearly 511,000 shares, compared with a daily average of about 1.5 million.Price: 21.07, Change: +0.25, Percent Change: +1.18","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660469590","title":"Acadia Realty Trust Price Target Announced at $25.00/Share by Keybanc","url":"https://stock-news.laohu8.com/highlight/detail?id=2660469590","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660469590?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:20","pubTimestamp":1787048400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AKR/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660453157","title":"Acadia Realty Trust upgraded to Overweight from Sector Weight at KeyBanc","url":"https://stock-news.laohu8.com/highlight/detail?id=2660453157","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660453157?lang=en_us&edition=fundamental","pubTime":"2026-08-18 08:55","pubTimestamp":1787014513,"startTime":"0","endTime":"0","summary":"KeyBanc analyst Todd Thomas upgraded Acadia Realty Trust (AKR) to Overweight from Sector Weight with a $25 price target Published first on TheFly –...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/acadia-realty-trust-upgraded-to-overweight-from-sector-weight-at-keybanc-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/acadia-realty-trust-upgraded-to-overweight-from-sector-weight-at-keybanc-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660435116","title":"Acadia Pharmaceuticals is Maintained at Buy by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2660435116","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660435116?lang=en_us&edition=fundamental","pubTime":"2026-08-17 22:38","pubTimestamp":1786977480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ACAD/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659712276","title":"Acadia Realty Trust Earnings Call Signals Street Retail Strength","url":"https://stock-news.laohu8.com/highlight/detail?id=2659712276","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659712276?lang=en_us&edition=fundamental","pubTime":"2026-08-15 08:19","pubTimestamp":1786753188,"startTime":"0","endTime":"0","summary":"Acadia Realty Trust (($AKR)) has held its Q2 earnings call. Read on for the main highlights of the call. Acadia Realty Trust’s latest earnings call...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/acadia-realty-trust-earnings-call-signals-street-retail-strength?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/acadia-realty-trust-earnings-call-signals-street-retail-strength?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658552930","title":"Acadia Pharmaceuticals to Gain From Daybue, Nuplazid Growth; RADIANT Data Adds Risk, Morgan Stanley Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658552930","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658552930?lang=en_us&edition=fundamental","pubTime":"2026-08-10 23:33","pubTimestamp":1786376001,"startTime":"0","endTime":"0","summary":"Acadia Pharmaceuticals (ACAD) could benefit from wider Daybue use, steady Nuplazid growth, higher cash flow and a strong balance sheet, but upcoming Remlifanserin trial data and the stock's valuation ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2065169927.USD","BK4231","BK4080","AKR","ACAD","LU2065170008.USD","BK4139","LU2065171402.SGD","LU2065171311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657757998","title":"Acadia Realty Trust Declares USD 0.20 Quarterly Dividend Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2657757998","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657757998?lang=en_us&edition=fundamental","pubTime":"2026-08-06 05:22","pubTimestamp":1785964969,"startTime":"0","endTime":"0","summary":"Acadia Realty Trust declares USD 0.20 quarterly dividend per shareAcadia Realty Trust declared a quarterly cash dividend of USD 0.2 per common share for the quarter ended Sept. 30, 2026.The dividend i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL9kjGpT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKR","BK4231","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657521539","title":"Acadia Pharmaceuticals is Maintained at Perform by Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2657521539","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657521539?lang=en_us&edition=fundamental","pubTime":"2026-08-06 01:25","pubTimestamp":1785950700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ACAD/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065170008.USD","BK4080","LU2065171311.SGD","AKR","BK4231","LU2065169927.USD","OPY","BK4139","BK4127","LU2065171402.SGD","ACAD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657525123","title":"Acadia Pharmaceuticals: Buy Rating Reiterated as Growth Drivers Strengthen; Price Target Maintained at $36","url":"https://stock-news.laohu8.com/highlight/detail?id=2657525123","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657525123?lang=en_us&edition=fundamental","pubTime":"2026-08-05 23:15","pubTimestamp":1785942925,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Malcolm Hoffman from BMO Capital maintained a Buy rating on ACADIA Pharmaceuticals, with a price target of $36.00. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/acadia-pharmaceuticals-buy-rating-reiterated-as-growth-drivers-strengthen-price-target-maintained-at-36-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/acadia-pharmaceuticals-buy-rating-reiterated-as-growth-drivers-strengthen-price-target-maintained-at-36-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657541783","title":"Acadia Pharmaceuticals price target raised to $25 from $23 at Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2657541783","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657541783?lang=en_us&edition=fundamental","pubTime":"2026-08-05 19:51","pubTimestamp":1785930711,"startTime":"0","endTime":"0","summary":"Oppenheimer raised the firm’s price target on Acadia Pharmaceuticals (ACAD) to $25 from $23 and keeps a Perform rating on the shares. The firm note...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/acadia-pharmaceuticals-price-target-raised-to-25-from-23-at-oppenheimer-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/acadia-pharmaceuticals-price-target-raised-to-25-from-23-at-oppenheimer-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AKR","OPY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657751022","title":"Acadia Pharmaceuticals price target raised to $36 from $35 at Citizens","url":"https://stock-news.laohu8.com/highlight/detail?id=2657751022","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657751022?lang=en_us&edition=fundamental","pubTime":"2026-08-05 17:45","pubTimestamp":1785923144,"startTime":"0","endTime":"0","summary":"Citizens analyst Jason Butler raised the firm’s price target on Acadia Pharmaceuticals (ACAD) to $36 from $35 and keeps an Outperform rating on the...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/acadia-pharmaceuticals-price-target-raised-to-36-from-35-at-citizens-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/acadia-pharmaceuticals-price-target-raised-to-36-from-35-at-citizens-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657962715","title":"Neuren Pharmaceuticals Partner Acadia Reports Record Q2 Daybue Sales; Shares Up 17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657962715","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657962715?lang=en_us&edition=fundamental","pubTime":"2026-08-05 09:23","pubTimestamp":1785893034,"startTime":"0","endTime":"0","summary":"Neuren Pharmaceuticals  reported a strong second-quarter update from partner Acadia Pharmaceuticals, with Daybue sales reaching a record $125 million, marking a 30% year-on-year increase and a 24% rise from the previous quarter, according to a Wednesday filing with the Australian bourse.Acadia increased its 2026 Daybue sales guidance to $480 million to $510 million, supported by strong US adoption of the new STIX formulation, with 40% of patients transitioning by the end of the quarter, per the filing.The company highlighted its global expansion progress, including a positive opinion from the Committee for Medicinal Products for Human Use supporting European approval and plans for a potential German launch in the fourth quarter.The company reported $12.9 million in the second quarter royalty earnings and raised its 2026 royalty guidance to $53 million to $56 million, the filing added.The company's shares jumped 17% in recent Wednesday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657562582","title":"Acadia Pharmaceuticals reports Q2 EPS 18c, consensus 4c","url":"https://stock-news.laohu8.com/highlight/detail?id=2657562582","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657562582?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:41","pubTimestamp":1785876068,"startTime":"0","endTime":"0","summary":"Reports revenue $308M, consensus $295.52M. “Acadia delivered an outstanding second quarter, highlighted by strong commercial execution across both ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/acadia-pharmaceuticals-reports-q2-eps-18c-consensus-4c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/acadia-pharmaceuticals-reports-q2-eps-18c-consensus-4c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657625805","title":"Acadia raises FY26 revenue view to $1.24B-$1.3B from $1.22B-$1.28B","url":"https://stock-news.laohu8.com/highlight/detail?id=2657625805","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657625805?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:40","pubTimestamp":1785876052,"startTime":"0","endTime":"0","summary":"Consensus $1.24B. NUPLAZID net product sales in the range of $760 to $790 million. DAYBUE global net product sales in the range of $480 to $510 mil...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/acadia-raises-fy26-revenue-view-to-1-24b-1-3b-from-1-22b-1-28b-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/acadia-raises-fy26-revenue-view-to-1-24b-1-3b-from-1-22b-1-28b-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656309838","title":"Acadia Realty Trust is Maintained at Buy by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2656309838","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656309838?lang=en_us&edition=fundamental","pubTime":"2026-08-04 03:15","pubTimestamp":1785784500,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AKR/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKR"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.acadiarealty.com","stockEarnings":[{"period":"1week","weight":-0.0062},{"period":"1month","weight":-0.056},{"period":"3month","weight":-0.0509},{"period":"6month","weight":-0.001},{"period":"1year","weight":0.0476},{"period":"ytd","weight":0.0175}],"compareEarnings":[{"period":"1week","weight":0.0111},{"period":"1month","weight":0.0408},{"period":"3month","weight":0.0193},{"period":"6month","weight":0.1241},{"period":"1year","weight":0.1925},{"period":"ytd","weight":0.1308}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Acadia Realty Trust is an equity real estate investment trust focused on delivering long-term, profitable growth via its dual  Core Portfolio and Fund  operating platforms and its disciplined, location-driven investment strategy. Acadia Realty Trust is accomplishing this goal by building a best-in-class core real estate portfolio with meaningful concentrations of assets in the nation's most dynamic corridors; making profitable opportunistic and value-add investments through its series of discretionary, institutional funds; and maintaining a strong balance sheet.","yearOnYearQuotes":[{"month":1,"riseRate":0.606061,"avgChangeRate":0.019474},{"month":2,"riseRate":0.515152,"avgChangeRate":0.00617},{"month":3,"riseRate":0.606061,"avgChangeRate":-0.008102},{"month":4,"riseRate":0.484848,"avgChangeRate":0.015676},{"month":5,"riseRate":0.424242,"avgChangeRate":-0.005165},{"month":6,"riseRate":0.5,"avgChangeRate":0.001528},{"month":7,"riseRate":0.617647,"avgChangeRate":0.018179},{"month":8,"riseRate":0.470588,"avgChangeRate":-0.004232},{"month":9,"riseRate":0.424242,"avgChangeRate":-0.006145},{"month":10,"riseRate":0.515152,"avgChangeRate":-0.004545},{"month":11,"riseRate":0.515152,"avgChangeRate":0.013024},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.008041}],"exchange":"NYSE","name":"Acadia","nameEN":"Acadia"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.48.0","shortVersion":"4.48.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Acadia(AKR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Acadia(AKR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Acadia,AKR,Acadia股票,Acadia股票老虎,Acadia股票老虎国际,Acadia行情,Acadia股票行情,Acadia股价,Acadia股市,Acadia股票价格,Acadia股票交易,Acadia股票购买,Acadia股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Acadia(AKR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Acadia(AKR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}